The impact of comprehensive treatment on pregnancy outcomes in patients with polycystic ovary syndrome

This study focuses on the impact of comprehensive treatment on pregnancy outcomes in patients with polycystic ovary syndrome (PCOS). In this research, 60 PCOS patients admitted to our hospital between January 2022 and April 2023 were selected and randomly divided into two groups. The control group (n=30) received conventional Western medical treatment, while the observation group (n=30) received integrated traditional Chinese and Western medicine treatment. The two groups were compared in terms of sex hormone levels, endometrial receptivity indices, pregnancy outcomes, incidence of adverse reactions, overall treatment efficacy, and Traditional Chinese Medicine (TCM) syndrome scores. The study found that before treatment, there were no significant differences between the two groups in terms of sex hormone levels, endometrial receptivity indices, and TCM syndrome scores (P>0.05). After treatment, the observation group showed significantly better results than the control group in these indices (P<0.05). The pregnancy outcomes in the observation group were superior to those in the control group (P<0.05), the incidence of adverse reactions was lower in the observation group (P<0.05), and the overall clinical efficacy was higher in the observation group (P>0.05). In conclusion, comprehensive treatment combining traditional Chinese and Western medicine can improve pregnancy outcomes in PCOS patients and is worthy of promotion.